Tri-Luma Cream is the only FDA-approved melasma treatment that contains three active components that are uniquely blended and more effective than therapies that only contain two.
TriLuma Cream is a novel triple-combination topical medication for the treatment of dark spots associated with moderate-to-severe facial melasma over a short period of time (eight weeks).
Fluocinolone acetonide 0.01 percent is a non-steroidal anti-inflammatory drug.
Hydroquinone 4 percent is a depigmenting chemical that helps lighten the skin by interfering with the development and synthesis of melanin.
Tretinoin 0.05 percent helps exfoliate the skin by boosting the rate of skin cell turnover.
TriLuma Cream should always be used in conjunction with UV protection, such as sunscreen and protective clothing. Melasma can be improved with Tri-Luma Cream, but it is not a cure.
Melasma is treated with a cream containing the medication combination fluocinolone acetonide/hydroquinone/tretinoin.
Frequently Asked Questions
When does Tri-Luma Cream begin working?
Tri-Luma Cream (fluocinolone acetonide 0.01 per cent, hydroquinone 4 per cent, tretinoin 0.05 per cent) is used to treat moderate-to-severe melasma of the face for up to 8 weeks. It’s not meant to be used for a long time (more than 8 weeks) or to keep melasma symptoms at bay.
Patients in tests saw relief in their melasma as soon as 4 weeks after using Tri-Luma Cream. Most patients saw some improvement after 8 weeks of treatment with this Melasma Cream. Some people’s dark spots disappeared completely (38 per cent in one trial and 13% in another), but most people’s melasma returned once treatment was stopped.
What is Tri Luma Cream used for?
Tri-Luma® Cream is a unique triple-combination topical therapy for the short-term (8-week ) treatment of the dark spots associated with moderate-to-severe facial melasma.